Quality Analysis and Suggestion for Ginkgo Folium Tablets and Ginkgo Folium Capsules

Li-na LIU; Hong-yu JIN; Yao-lei LI; Wei-yi XU; Ying WANG; Ke ZAN; Shuang-cheng MA

doi:10.13422/j.cnki.syfjx.20201750

您当前的位置：

首页 >

文章列表页 >

Quality Analysis and Suggestion for Ginkgo Folium Tablets and Ginkgo Folium Capsules

更新时间：2021-12-03

- Quality Analysis and Suggestion for Ginkgo Folium Tablets and Ginkgo Folium Capsules
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 1, Pages: 147-153(2021)
- 作者机构：
  
  中国食品药品检定研究院，北京 100050
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20201750
  CLC： R22;R9;R28;S792.95
- Received：31 March 2020，
  
  Published Online：09 June 2020，
  
  Published：05 January 2021
- 稿件说明：
移动端阅览
刘丽娜,金红宇,李耀磊等.银杏叶片及银杏叶胶囊的质量分析及建议[J].中国实验方剂学杂志,2021,27(01):147-153.

LIU Li-na,JIN Hong-yu,LI Yao-lei,et al.Quality Analysis and Suggestion for Ginkgo Folium Tablets and Ginkgo Folium Capsules[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(01):147-153.
刘丽娜,金红宇,李耀磊等.银杏叶片及银杏叶胶囊的质量分析及建议[J].中国实验方剂学杂志,2021,27(01):147-153. DOI： 10.13422/j.cnki.syfjx.20201750.

LIU Li-na,JIN Hong-yu,LI Yao-lei,et al.Quality Analysis and Suggestion for Ginkgo Folium Tablets and Ginkgo Folium Capsules[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(01):147-153. DOI： 10.13422/j.cnki.syfjx.20201750.

摘要

目的

比较目前市场上不同厂家的银杏叶片及银杏叶胶囊样品，对质量差异进行分析，并对二者的质量标准提高和市场监管提出建议。

方法

按照2015年版《中国药典》（一部）银杏叶片及银杏叶胶囊含量测定项方法测定了银杏叶片及银杏叶胶囊中总黄酮醇苷及萜类内酯的含量，按照国家药品监督管理局发布的银杏叶片及银杏叶胶囊相关补充检验方法，对银杏叶片及银杏叶胶囊中游离黄酮（槲皮素、山柰素、异鼠李素）及槐角苷检查项进行了测定，并对48家企业生产的328批银杏叶片及银杏叶胶囊的总黄酮醇苷、萜类内酯含量测定项以及游离黄酮、槐角苷检查项进行分析，比较不同批次及不同厂家银杏叶制剂的质量差异。

结果

328批银杏叶片及银杏叶胶囊质量均符合标准规定，但总黄酮醇苷及萜类内酯含量分布范围均较宽，不同企业间样品质量差异较大。

结论

建议各企业对工艺进行优化，对原材料进行严格控制，以保证样品的批间一致性。

Abstract

Objective

To conduct quality evaluation of Ginkgo Folium preparations by analyzing the national evaluation sampling test results， analyze the quality differences， and put forward suggestions for the improvement of quality standards and market supervision.

Method

The contents of total flavonol glycosides and terpene lactones in Ginkgo Folium tablets and Ginkgo Folium capsules were determined according to the methods of determination in the 2015 edition of

Chinese Pharmacopoeia

（the first volume）， and the contents of free flavonoids （quercetin， kaempferide and isorhamnetin） and sophoricoside in Ginkgo Folium preparations were determined according to related supplementary testing method of Ginkgo Folium tablets and Ginkgo Folium capsules issued by National Medical Products Administration. The quality differences of Ginkgo Folium preparations from different batches and different manufacturers were compared according to the contents of total flavonol glycosides， terpene lactones， free flavonoids and sophoricoside in 328 batches of Ginkgo Folium tablets and Ginkgo Folium capsules manufactured by 48 enterprises.

Result

Quality of 328 batches of Ginkgo Folium tablets and Ginkgo Folium capsules was in accordance with the standard， but the contents of terpene lactones and total flavonol glycosides were all distributed in a wide range， and the quality of samples varied greatly among different enterprises.

Conclusion

It is recommended that each enterprise should optimize the production process and strictly control the raw materials to ensure the consistency between different batches of samples.

关键词

Keywords

references

刘丽娜，金红宇，何轶，等 . 银杏叶提取物及其制剂质量监督专项工作中的风险控制［J］. 药物分析杂志， 2017 ， 37 （ 6 ）： 1081 - 1086 .

刘丽娜，何轶，李耀磊，等 . 银杏叶提取物及其制剂补充检验方法的建立［J］. 药物分析杂志， 2016 ， 36 （ 5 ）： 856 - 862 .

国家药典委员会 . 中华人民共和国药典：一部［M］. 北京：中国医药科技出版社， 2015 ： 416 .

美国药典委员会 . 美国药典（USP 40-NF 35）［M］. 马里兰：美国药典委员会， 2017 ： 7005 .

欧洲药典委员会 . 欧洲药典（EP 9 . 0）［M］. 斯特拉斯堡：欧洲药品质量管理局， 2017 ： 1368 .

王劼，袁林，厉进忠，等 . 银杏叶提取物制剂中萜类内酯含量考察［J］. 中国药学杂志， 1998 ， 33 （ 11 ）： 655 - 657 .

STRØMGAARD K ， NAKANISHI K . Chemistry and biology of terpene trilactones from Ginkgo biloba ［J］. Angew Chem Int Ed Engl ， 2004 ， 43 （ 13 ）： 1640 - 1658 .

HUANG S H ， DUKE R K ， CHEBIB M ， et al . Bilobalide，a sesquiterpene trilactone from Ginkgo biloba ，is an antagonist at recombinant α 1 β 2 γ 2L GABA A receptors ［J］. Eur J Pharmcol ， 2003 ， 464 （ 1 ）： 1 - 8 .

WEICHEL O ， HILGERT M ， CHATTERJEE S S ， et al . Bilobalide，a constituent of Ginkgo biloba ，inhibits NMDA-induced phospholipase A 2 activation and phospholipid breakdown in rat hippocampus ［J］. Naunyn Schmiedebergs Arch Pharmacol ， 1999 ， 360 （ 6 ）： 609 - 615 .

KLEIN J ， CHATTEEJEE S S ， LÖFFELHOLZ K . Phospholipid breakdown and choline release under hypoxic conditions：inhibition by bilobalide，a constituent of Ginkgo biloba ［J］. Brain Res ， 1997 ， 755 （ 2 ）： 347 - 350 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Characteristic ion Identification of Different Original Haliotidis Concha and Its Counterfeits

Quality Evaluation of Clinical Guidelines for Acute Myocardial Infarction Based on AGREE Ⅱ

Analysis on Quality Standard of Hedyotis Herba Dispensing Granules Based on Standard Decoction

Processing History and Modern Research of Jianghuanglian： A Review

Quality Evaluation of Lycii Cortex and Roasted Lycii Cortex Based on Fingerprint and Content Determination

Related Author

LIANG Xiaojie

LI Guowei

ZHOU Lin

HU Qiping

LUO Muxiang

TANG Jiehao

CHEN Xiangdong

PAN Liye

Related Institution

Guangzhou University of Chinese Medicine

Guangdong Provincial Enterprise Key Laboratory of Traditional Chinese Medicine Formula Granule，Guangdong Efong Pharmaceutical Co. Ltd.

China Pharmaceutical University

Southern Medical University

Guangdong Pharmaceutical University

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰